{
 "drug": "Fosaprepitant Dimeglumine Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "04/08/2026",
 "dayN": 139,
 "cat": "Gastroenterology",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "04/08/2026",
   "update_type": "New",
   "initial_posting_date": "04/08/2026",
   "package_ndc": "63323-972-10",
   "generic_name": "Fosaprepitant Dimeglumine Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA206197"
    ],
    "brand_name": [
     "FOSAPREPITANT"
    ],
    "generic_name": [
     "FOSAPREPITANT"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-972"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "FOSAPREPITANT DIMEGLUMINE"
    ],
    "rxcui": [
     "1731077"
    ],
    "spl_id": [
     "864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c"
    ],
    "spl_set_id": [
     "ffee61d1-c1c6-4224-871c-ab7ff6cd01e5"
    ],
    "package_ndc": [
     "63323-972-10"
    ],
    "unii": [
     "D35FM8T64X"
    ]
   },
   "update_date": "04/08/2026",
   "therapeutic_category": [
    "Gastroenterology"
   ],
   "dosage_form": "Injection",
   "presentation": "Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}